Outcome of the 40th Annual General Meeting

Sandu Pharmaceuticals held its 40th AGM on September 30, 2025, via video conferencing, with all 6 directors, auditors, CFO, and Company Secretary in attendance. All 8 ordinary resolutions put to vote were passed through e-voting. Key items approved include adoption of audited standalone and consolidated financial statements for FY25, declaration of a dividend on equity shares for FY ended March 31, 2025, and reappointment of Shri Shashank Sandu (who retires by rotation). Shareholders also approved the modification of a material related party transaction with Sandu Brothers Private Limited, ratification of the Cost Auditor's remuneration, continuation of Shri Vijay Kajarakar as CFO past age 70, and appointment of M/s Swapnil J Dixit & Associates as Secretarial Auditor for a five-year term. Voting results were to be declared within 48 hours of the meeting's conclusion.